HomeCompareJNJ vs CMG

JNJ vs CMG: Dividend Comparison 2026

JNJ yields 2.14% · CMG yields 6.41%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CMG wins by $96.00 in total portfolio value
10 years
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →
CMG
CMG
● Live price
6.41%
Share price
$31.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.6K
Annual income
$964.82
Full CMG calculator →

Portfolio growth — JNJ vs CMG

📍 CMG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJNJCMG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JNJ + CMG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JNJ pays
CMG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
CMG
Annual income on $10K today (after 15% tax)
$545.22/yr
After 10yr DRIP, annual income (after tax)
$820.10/yr
At 15% tax rate, JNJ beats the other by $3,217.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JNJ + CMG for your $10,000?

JNJ: 50%CMG: 50%
100% CMG50/50100% JNJ
Portfolio after 10yr
$30.5K
Annual income
$2,857.35/yr
Blended yield
9.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CMG right now

JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
CMG
Analyst Ratings
46
Buy
20
Hold
Consensus: Buy
Price Target
$44.35
+42.2% upside vs current
Range: $35.00 — $52.00
Altman Z
6.2
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JNJ buys
8
CMG buys
0
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJNJCMG
Forward yield2.14%6.41%
Annual dividend / share$5.20$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR28%0%
Portfolio after 10y$30.5K$30.6K
Annual income after 10y$4,749.88$964.82
Total dividends collected$15.6K$8.1K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyBuy
Analyst price target$228.73$44.35

Year-by-year: JNJ vs CMG ($10,000, DRIP)

YearJNJ PortfolioJNJ Income/yrCMG PortfolioCMG Income/yrGap
1← crossover$10,594$274.49$11,341$641.44$747.00CMG
2$11,294$360.69$12,815$679.89$1.5KCMG
3$12,133$476.91$14,430$717.98$2.3KCMG
4$13,156$635.42$16,196$755.57$3.0KCMG
5$14,432$854.61$18,122$792.55$3.7KCMG
6$16,056$1,162.76$20,220$828.79$4.2KCMG
7$18,175$1,604.53$22,499$864.22$4.3KCMG
8$21,009$2,252.68$24,973$898.74$4.0KCMG
9$24,911$3,229.73$27,653$932.29$2.7KCMG
10$30,458$4,749.88$30,554$964.82$96.00CMG

JNJ vs CMG: Complete Analysis 2026

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

CMGStock

Chipotle Mexican Grill, Inc., together with its subsidiaries, owns and operates Chipotle Mexican Grill restaurants. As of February 15, 2022, it owned and operated approximately 3,000 restaurants in the United States, Canada, the United Kingdom, France, Germany, and rest of Europe. The company was founded in 1993 and is headquartered in Newport Beach, California.

Full CMG Calculator →
📬

Get this JNJ vs CMG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JNJ vs ABBVJNJ vs MRKJNJ vs PFEJNJ vs BMYJNJ vs LLYJNJ vs SCHDJNJ vs JEPIJNJ vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.